Skip to main content

RTW Venture

data as at: 25/05/2020
Company website
ObjectiveTo achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
Management groupRTW Investments
AIC sectorBiotechnology & Healthcare
Launch date29/10/2019
Financial year endDecember
DomicileGuernsey

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Dividends

Dividends displayed in traded currency.

There have been no dividends in the last 12 months.

Dividend cover (years)Revenue reserves (m)
N/AN/A

Trading information

ISINTIDMTraded currency
GG00BKTRRM22RTWUSD

Traded volumes (number of shares)

Yesterday1 month1 year5 years
Total076,16500
AverageN/A3,62700

Traded values (m)

Yesterday1 month1 year5 years
Total0.000.100.000.00
AverageN/A0.000.000.00

Data provided by Morningstar. Company documents provided by Financial Express. 

Company announcements

Company documents